Nabriva Therapeutics GmbH

Autriche

Commandez votre montre hebdomadaire Nabriva Therapeutics GmbH
Quantité totale PI 16
Rang # Quantité totale PI 96 062
Note d'activité PI 1,9/5.0    11
Rang # Activité PI 81 283

Brevets

Marques

0 0
6 0
10 0
0
 
Dernier brevet 2024 - Lefamulin and its derivatives fo...
Premier brevet 2003 - Pleuromutilin derivatives having...

Derniers inventions, produits et services

2023 Invention Lefamulin and its derivatives for use in the treatment of tularemia. 333123-61-61-63-6121234321-6...
Invention Lefamulin and its derivatives for use in the treatment of a spiral shaped bacteria. 33311-623-61-...
2022 Invention Novel 12-epi-mutilin compounds and uses thereof. 111-622 is the compound for use as a medicament ...
2021 Invention Novel 12-epi-mutilin compounds, process for preparing the same and uses thereof. 00 is C1 or I, p...
Invention Novel therapeutic use of pleuromutilins. 33311-623-61-61-63-612123432p41-63-63-6)cycloalkyl, or a...
Invention Therapeutic use of pleuromutilins. 33123-61-61-63-61212343241-63-63-6)cycloalkyl, or a pharmaceut...
Invention Therapeutic use of pleuromutilins. A compound selected from 14-O-[((Alkyl-, cycloalkyl-, heterocy...
2020 Invention Siderophore cephalosporin conjugates and uses thereof. 233220-61-63-600parametameta-position to D...
2018 Invention Purification of pleuromutilin. The present invention relates to purification methods of pleuromut...
2016 Invention Injectable pharmaceutical formulations of lefamulin. The present invention relates to an injectab...
2003 Invention Pleuromutilin derivatives having antibacterial activity. A compound selected from 14—O—[(cycloalk...